Von Hippel-Lindau,
Showing 1 - 25 of 267
Patients With Von Hippel Lindau Disease
Not yet recruiting
- Von Hippel Lindau Disease
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2023
Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and
Not yet recruiting
- Von Hippel-Lindau Disease
- 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
- (no location specified)
Mar 30, 2023
Von Hippel-Lindau Disease, Genetic Disorder Trial in Boston (3RP-VHL)
Not yet recruiting
- Von Hippel-Lindau Disease
- Genetic Disorder
- 3RP-VHL
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 10, 2023
VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer
Recruiting
- VHL Pancreatic Neuroendocrine Tumors
- +2 more
- 68-Gallium DOTATATE
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Brain and Spinal Cord Tumor Growth and Cyst Development in Von
Active, not recruiting
- Hemangioblastoma
- Hippel Lindau Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Von Hippel-Lindau: Clinical Manifestations, Diagnosis,
Recruiting
- Kidney Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hemangioblastoma of CNS, Von Hippel-Lindau Disease Trial in Le Kremlin Bicêtre (Propranolol, follow-up)
Not yet recruiting
- Hemangioblastoma of CNS
- Von Hippel-Lindau Disease
- Propranolol
- follow-up
-
Le Kremlin Bicêtre, FranceAP-HP, Bicêtre Hospital
Jun 14, 2022
VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)
Active, not recruiting
- VHL - Von Hippel-Lindau Syndrome
- +5 more
-
Bethesda, Maryland
- +10 more
Aug 16, 2022
Adenocarcinoma, Prostate Tumors, Prostate Cancer Trial run by the National Institutes of Health Clinical Center (CC) (EM
Enrolling by invitation
- Adenocarcinoma
- +4 more
- EM Tracking
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)
Completed
- Von Hippel-Lindau Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 21, 2021
Von Hippel-Lindau Disease, Hereditary Leiomyomatosis and Renal Cell Cancer, Birt-Hogg-Dube Syndrome Trial in Boston
Recruiting
- Von Hippel-Lindau Disease
- +3 more
-
Boston, MassachusettsVHL Alliance
Oct 4, 2021
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)
Recruiting
- Pheochromocytoma/Paraganglioma
- +2 more
-
Los Angeles, California
- +58 more
Jan 27, 2023
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Frequency, Clinical Phenotype and Genetic Analysis of Heritable
Not yet recruiting
- Renal Tumor Histology
- +13 more
- Gene test
-
Shanghai, Shanghai, ChinaEthics Committee of Shanghai Renji Hospital
Sep 6, 2022
Meningioma, Metastatic Well Differentiated Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston (Computed
Terminated
- Meningioma
- +5 more
- Computed Tomography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2021
Von Hippel-Lindau Disease Genetic Epidemiology Study
Terminated
- Von Hippel Lindau Disease
- Kidney Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 9, 2020
Neurocutaneous Syndromes in Upper Egypt Children
Not yet recruiting
- Neurocutaneous Syndromes
- (no location specified)
Sep 10, 2023
Neuroendocrine Tumors, Von Hippel-Lindau Syndrome, Hippel-Lindau Disease Trial run by the NCI (68Gallium DOTATATE, Radio-guided
Completed
- Neuroendocrine Tumors
- +2 more
- 68Gallium DOTATATE
- Radio-guided surgery
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 8, 2019
Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic
Recruiting
- Renal Tumor Histology
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 28, 2022
Drivers of Hypoxia-induced Angiogenesis in Tumor Development
Unknown status
- Von Hippel-Lindau Disease
- Whole exome sequencing
-
Copenhagen, Denmark
- +1 more
Sep 25, 2019
Neuroendocrine Neoplasms Including Adrenocortical Carcinoma
Recruiting
- Neuroendocrine Tumors
- Carcinoma, Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Molecular Biology of Polycythemia and Thrombocytosis
Recruiting
- Polycythemia
- Thrombocytosis
-
Salt Lake City, UtahUniversity of Utah
Dec 28, 2022